A preliminary study has found that efavirenz — a non-nucleoside inhibitor of HIV virus that is used for treating HIV/AIDS — can be repurposed for the treatment of chikungunya. Currently ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscular as a single 0.8mL dose. Vimkunya ™ (chikungunya vaccine, recombinant) is now available in the US for ...

The chikungunya virus virus-like particle (CHIKV VLP) vaccine achieved 100% seroconversion in adults who had previously received alphavirus vaccines and alphavirus vaccine–naive control ...

Speaking to Daily Mirror, Consultant Physician Dr Achala Balasuriya said “Chikungunya is spread through ... fatigue, and skin rashes. While most patients recover within a week, joint pain ...

(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been hospitalized. On Tuesday, the U.S. Centers for Disease Control and Prevention ...

A mosquito-borne disease called chikungunya has killed two elderly people on France's Reunion Island, local authorities said on Friday. An 86-year-old and a 96-year-old died last week from the virus, ...

The vaccine, approved in November 2023, is recommended for adults traveling somewhere with a chikungunya outbreak. Chikungunya is a mosquito-borne disease that causes fever and joint pain.

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

Rashes can be maddeningly itchy, no matter what the cause. Doctors are likely to prescribe creams, lotions, or antihistamines for relief. They may also suggest cold compresses or other home remedies.